Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about IONS

Recent news which mentions IONS

< Previous 1 2 3 4 5 6 Next >
FDA grants accelerated approval to Biogen treatment for rare form of ALS
Tickers BIIB IONS
Tags IONS BIIB
From MarketWatch
What's Going On With Biogen Stock Tuesday?
Tickers BIIB IONS
Tags Earnings FDA Movers
From Benzinga
Biogen Announces Additional Cost Cutting Initiatives, Chops Certain Stroke, Gene Therapy Programs
Tickers BIIB IONS
Tags Market News Health Care Earnings
From Benzinga
3 Biotech Stocks to Sell Before They’re 6 Feet Under
Tickers ACRS AMRS IONS
Tags NASDAQ:AMRS,NASDAQ:ACRS,NASDAQ:IONS AMRS Stocks to Sell
From InvestorPlace
AstraZeneca, Ionis Unveil Complete Phase 3 Data For ATTR Candidate, Says Drug Halts Disease Progression
Tickers AZN AZNCF IONS
Tags News Market News AZN
From Benzinga
Could This Rare-Disease Drug Candidate Become a Blockbuster?
Tickers AZN IONS
Tags AZN Market News Recent Press Releases
From Motley Fool
Analyst Upgrades Arrowhead Pharma Citing 'Attractive Risk/Reward'
Tickers ALNY ARWR IONS MRNA
Tags Benzinga NVO ARWR
From Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
Tickers IONS
Tags Market News Analyst Ratings Benzinga
From Benzinga
AstraZeneca-Ionis Partnered Rare Disease Drug Data Shows Sustained Benefit; Drug Under FDA Review
Tickers AZN AZNCF BXRX IONS
Tags General Benzinga Briefs
From Benzinga
FDA Adcomm Says Benefit-Risk Profile Favor Biogen's Tofersen For Inherited Neuro Disorder
Tickers BIIB IONS
Tags Biotech Briefs IONS
From Benzinga
Analyst Ratings for Ionis Pharmaceuticals
Tickers IONS
Tags Market News Analyst Ratings BZI/AAR
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023
Tickers ADC AIZ ALLO ALNY
Tags OSH IONS Intraday Update
From Benzinga
Wall Street predicts approval for another ALS drug
Tickers AMLX BIIB IONS
Tags IONS BIIB AMLX
From MarketWatch
Biogen Triumphs In Legal Battle Regarding Tecfidera, Delaying EU Generic Erosion For Another Year
Tickers BIIB IONS
Tags Market News Expert Ideas News
From Benzinga
Ionis Pharmaceuticals's Earnings Outlook
Tickers IONS
Tags BZI/EP Earnings IONS
From Benzinga
Analyst Says Ionis' Additional Hereditary Angioedema Study Data Supports 'Highly Competitive Profile'
Tickers IONS
Tags Analyst Color Market News Reiteration
From Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
Tickers IONS
Tags IONS Market News Analyst Ratings
From Benzinga
EXAS Nears Key Buy Signal in Active Biotech ETF ARKG
Tickers ARKG EXAS IONS PACB
Tags PACB disruptive technology channel golden crossover
From ETF Trends
The Latest Analyst Ratings for Ionis Pharmaceuticals
Tickers IONS
Tags Market News Benzinga BZI/AAR
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 21, 2022
Tickers ADPT AIMC AMV APPN
Tags PINE KEY AIMC
From Benzinga
Ionis Pharmaceuticals Earnings Perspective: Return On Capital Employed
Tickers IONS
Tags Benzinga Market News IONS
From Benzinga
Gene Deal Adds New Dimension to Biotech ETF SBIO
Tickers ALPS IONS SBIO
Tags SBIO ETF Building Blocks Channel SS&C
From ETF Trends
4 Analysts Have This to Say About Ionis Pharmaceuticals
Tickers IONS
Tags Benzinga BZI/AAR Analyst Ratings
From Benzinga
Phillips 66 To Rally 25%? Here Are 5 Other Price Target Changes For Thursday
Tickers HCAT IONS PSX RSKD
Tags Small Cap Trading Ideas Penny Stocks
From Benzinga
Ionis Regains Rights To Thrombosis Candidate From Bayer
Tickers BAYRY BAYZF IONS
Tags General Benzinga IONS
From Benzinga
3 Biotech Stocks to Sell in October
Tickers GILD GLPG ILMN IONS
Tags Stocks to Sell IONS GILD
From InvestorPlace
AstraZeneca Pulls Plug On Ionis Pharma-Partnered Cholesterol Med
Tickers AZN AZNCF IONS
Tags Health Care why it's moving Market News
From Benzinga
This Stock Has Delivered a Gain of 100% Over the Past 3 Months. Can You Still Buy?
Tickers AMLX BIIB IONS
Tags IONS BIIB AMLX
From Motley Fool
There's 'Outsized' Risk-Reward For This Biotech, Morgan Stanley Says, Predicting Shares Could Grow More Than 30%
Tickers IONS
Tags IONS Price Target General
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
Tickers ADCT ALEC ANNX ARVN
Tags PRGS OMCL IONS
From Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.